Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : firstname.lastname@example.org
|Synonyms||OMP313M32|OMP 313M32|OMP-313M32|WHO 10742|MPH313|
Etigilimab (OMP-313M32) is an anti-human TIGIT (T cell immunoreceptor with Ig ITIM domain) antibody that potentially has anti-tumor activities through modulating the immune response to tumors (AACR, Vol 58, April 2017, Abstract #599, PMID: 31874056).
|DrugClasses||Immune Checkpoint Inhibitor 153 TIGIT Antibody 18|
|CAS Registry Number||2044984-83-8|
|Therapy Name||Drugs||Efficacy Evidence||Clinical Trials|
|Etigilimab + Nivolumab||Etigilimab Nivolumab||0||3|